TYMS and colorectal carcinoma: Unfortunately, HSP90 did not fully reflect the short-term efficacy of first-line treatment in patients with CRC although HSP90 inhibition downregulates thymidylate synthase and thus synergizes with fluoropyrimidine-based chemotherapy in CRC cell lines and xenograft models 22,23.